MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
Abstract Chemoresistance constitutes a major challenge in the treatment of triple-negative breast cancer (TNBC). Mixed-Lineage Kinase 4 (MLK4) is frequently amplified or overexpressed in TNBC where it facilitates the aggressive growth and migratory potential of breast cancer cells. However, the func...
Guardado en:
Autores principales: | Dawid Mehlich, Michał Łomiak, Aleksandra Sobiborowicz, Alicja Mazan, Dagmara Dymerska, Łukasz M. Szewczyk, Anna Mehlich, Agnieszka Borowiec, Monika K. Prełowska, Adam Gorczyński, Paweł Jabłoński, Ewa Iżycka-Świeszewska, Dominika Nowis, Anna A. Marusiak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a6cbcdae3c1744a89c3691e28b0246d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
por: Aurélie S. Cazet, et al.
Publicado: (2018) -
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Sajad Dar, et al.
Publicado: (2017) -
Palmatine sensitizes chemoresistant triple negative breast cancer cells via efflux inhibition of multidrug resistant protein 1.
por: Selase Ativui, et al.
Publicado: (2021) -
MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Prabir K. Chakraborty, et al.
Publicado: (2017) -
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Miguel Angel Merlos Rodrigo, et al.
Publicado: (2021)